Elevated Malat1 expression in infected HSCs reduces fibrosis by downregulating miR-96 and upregulating Smad7, thus providing a novel therapeutic target for schistosomiasis hepatic fibrosis. Here, MALAT1 is linked to Hepatic fibrosis.